findmyKOL
Clinical trialNCT00417872CompletedPhase 2Interventional

Study of Nitazoxanide in the Treatment of Clostridium Difficile Colitis

SponsorRomark Laboratories L.C.Enrollment114Clostridium Difficile
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

7 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Bayfront Medical Center and Edward White Hospital

    St. Petersburg, Florida, United States

  • Wellstar Infectious Diseases

    Marietta, Georgia, United States

  • Remington-Davis, Inc., and Riverside Infection Consultants, Inc.

    Columbus, Ohio, United States

  • Lehigh Valley Hospital

    Allentown, Pennsylvania, United States

  • the Reading Hospital and Medical Center

    West Reading, Pennsylvania, United States

  • Houston Veterans Affairs Hospital

    Houston, Texas, United States

  • St. Luke'S Episcopal Hospital

    Houston, Texas, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 Jan 2004
Primary completion
Completion
30 Sept 2005
Last update posted
4 Jan 2007
Registered enrollment
114
Registry id
NCT00417872

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.